nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.243	0.368	CbGbCtD
Morphine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.165	0.249	CbGbCtD
Morphine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.155	0.235	CbGbCtD
Morphine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0986	0.149	CbGbCtD
Morphine—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.067	CcSEcCtD
Morphine—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0561	CcSEcCtD
Morphine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00954	0.0303	CcSEcCtD
Morphine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.0186	CcSEcCtD
Morphine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.0179	CcSEcCtD
Morphine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.0167	CcSEcCtD
Morphine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.0167	CcSEcCtD
Morphine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00521	0.0165	CcSEcCtD
Morphine—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.0159	CcSEcCtD
Morphine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00461	0.0146	CcSEcCtD
Morphine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0134	CcSEcCtD
Morphine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.0131	CcSEcCtD
Morphine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.0127	CcSEcCtD
Morphine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.0127	CcSEcCtD
Morphine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.0121	CcSEcCtD
Morphine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.012	CcSEcCtD
Morphine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.0119	CcSEcCtD
Morphine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.0118	CcSEcCtD
Morphine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0116	CcSEcCtD
Morphine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0115	CcSEcCtD
Morphine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.0112	CcSEcCtD
Morphine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.0112	CcSEcCtD
Morphine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.0111	CcSEcCtD
Morphine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.011	CcSEcCtD
Morphine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.0108	CcSEcCtD
Morphine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.0106	CcSEcCtD
Morphine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.0105	CcSEcCtD
Morphine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.0105	CcSEcCtD
Morphine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.0101	CcSEcCtD
Morphine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00974	CcSEcCtD
Morphine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.0097	CcSEcCtD
Morphine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.0096	CcSEcCtD
Morphine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00957	CcSEcCtD
Morphine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00925	CcSEcCtD
Morphine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00918	CcSEcCtD
Morphine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00903	CcSEcCtD
Morphine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00895	CcSEcCtD
Morphine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00859	CcSEcCtD
Morphine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00831	CcSEcCtD
Morphine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00828	CcSEcCtD
Morphine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00805	CcSEcCtD
Morphine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00798	CcSEcCtD
Morphine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00796	CcSEcCtD
Morphine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00796	CcSEcCtD
Morphine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00774	CcSEcCtD
Morphine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00737	CcSEcCtD
Morphine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00735	CcSEcCtD
Morphine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00731	CcSEcCtD
Morphine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00726	CcSEcCtD
Morphine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00722	CcSEcCtD
Morphine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00721	CcSEcCtD
Morphine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00708	CcSEcCtD
Morphine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00682	CcSEcCtD
Morphine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00667	CcSEcCtD
Morphine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00662	CcSEcCtD
Morphine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.0066	CcSEcCtD
Morphine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00644	CcSEcCtD
Morphine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0064	CcSEcCtD
Morphine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00631	CcSEcCtD
Morphine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00628	CcSEcCtD
Morphine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00627	CcSEcCtD
Morphine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00621	CcSEcCtD
Morphine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00615	CcSEcCtD
Morphine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00603	CcSEcCtD
Morphine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.006	CcSEcCtD
Morphine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00594	CcSEcCtD
Morphine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00591	CcSEcCtD
Morphine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00588	CcSEcCtD
Morphine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00577	CcSEcCtD
Morphine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00575	CcSEcCtD
Morphine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00573	CcSEcCtD
Morphine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00558	CcSEcCtD
Morphine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00554	CcSEcCtD
Morphine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00552	CcSEcCtD
Morphine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00545	CcSEcCtD
Morphine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00545	CcSEcCtD
Morphine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00543	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00541	CcSEcCtD
Morphine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00538	CcSEcCtD
Morphine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00533	CcSEcCtD
Morphine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00527	CcSEcCtD
Morphine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00522	CcSEcCtD
Morphine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00522	CcSEcCtD
Morphine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00519	CcSEcCtD
Morphine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00512	CcSEcCtD
Morphine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00511	CcSEcCtD
Morphine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00507	CcSEcCtD
Morphine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00505	CcSEcCtD
Morphine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00498	CcSEcCtD
Morphine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00476	CcSEcCtD
Morphine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00472	CcSEcCtD
Morphine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00469	CcSEcCtD
Morphine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00466	CcSEcCtD
Morphine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00464	CcSEcCtD
Morphine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0046	CcSEcCtD
Morphine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00454	CcSEcCtD
Morphine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00451	CcSEcCtD
Morphine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0045	CcSEcCtD
Morphine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00447	CcSEcCtD
Morphine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00447	CcSEcCtD
Morphine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0043	CcSEcCtD
Morphine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00427	CcSEcCtD
Morphine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00415	CcSEcCtD
Morphine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00413	CcSEcCtD
Morphine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00413	CcSEcCtD
Morphine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00385	CcSEcCtD
Morphine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00375	CcSEcCtD
Morphine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00369	CcSEcCtD
Morphine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00357	CcSEcCtD
Morphine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00345	CcSEcCtD
Morphine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00332	CcSEcCtD
Morphine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00329	CcSEcCtD
Morphine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00329	CcSEcCtD
Morphine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00327	CcSEcCtD
Morphine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.0031	CcSEcCtD
Morphine—OPRL1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000263	0.011	CbGpPWpGaD
Morphine—OPRM1—IL4-mediated signaling events—CD40LG—focal segmental glomerulosclerosis	0.000258	0.0108	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000244	0.0102	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000235	0.00986	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000226	0.00944	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00022	0.00922	CbGpPWpGaD
Morphine—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000212	0.00886	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000205	0.00859	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000203	0.00848	CbGpPWpGaD
Morphine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000197	0.00826	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000193	0.00808	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000187	0.00784	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000186	0.00778	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000172	0.00722	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000172	0.00719	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000169	0.00709	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.000163	0.00683	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000163	0.00682	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000151	0.00633	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00015	0.00627	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000149	0.00623	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000148	0.00622	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000148	0.00618	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000144	0.00601	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000143	0.00597	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000141	0.00589	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000138	0.00576	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000136	0.00571	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000136	0.00569	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000135	0.00566	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000134	0.00562	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000133	0.00555	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00013	0.00542	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000129	0.00541	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000128	0.00535	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000126	0.00527	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000125	0.00525	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000125	0.00524	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000119	0.00499	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000119	0.00497	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000116	0.00487	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000116	0.00487	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000115	0.00479	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000114	0.00476	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000114	0.00475	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000112	0.00471	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000109	0.00458	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000109	0.00457	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000106	0.00445	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000104	0.00437	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000104	0.00435	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000101	0.00421	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	9.96e-05	0.00417	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	9.95e-05	0.00417	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—LIPC—focal segmental glomerulosclerosis	9.9e-05	0.00414	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	9.86e-05	0.00413	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	9.82e-05	0.00411	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.71e-05	0.00406	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	9.63e-05	0.00403	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	8.87e-05	0.00371	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	8.83e-05	0.0037	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.82e-05	0.00369	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	8.81e-05	0.00369	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	8.81e-05	0.00369	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CTGF—focal segmental glomerulosclerosis	8.72e-05	0.00365	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—LIPC—focal segmental glomerulosclerosis	8.65e-05	0.00362	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—LIPC—focal segmental glomerulosclerosis	8.65e-05	0.00362	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	8.65e-05	0.00362	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	8.44e-05	0.00353	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	8.42e-05	0.00352	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	8.34e-05	0.00349	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.06e-05	0.00337	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.03e-05	0.00336	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.03e-05	0.00336	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	7.99e-05	0.00335	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.99e-05	0.00334	CbGpPWpGaD
Morphine—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	7.83e-05	0.00328	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	7.79e-05	0.00326	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CTGF—focal segmental glomerulosclerosis	7.62e-05	0.00319	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CTGF—focal segmental glomerulosclerosis	7.62e-05	0.00319	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.58e-05	0.00317	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	7.45e-05	0.00312	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	7.42e-05	0.00311	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	7.33e-05	0.00307	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.32e-05	0.00306	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	7.14e-05	0.00299	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.02e-05	0.00294	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.02e-05	0.00294	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	7.01e-05	0.00293	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.72e-05	0.00281	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.66e-05	0.00279	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.43e-05	0.00269	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	6.41e-05	0.00268	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	6.39e-05	0.00268	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	6.36e-05	0.00266	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.14e-05	0.00257	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	6.09e-05	0.00255	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—LPL—focal segmental glomerulosclerosis	6.04e-05	0.00253	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.01e-05	0.00251	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	5.92e-05	0.00248	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	5.81e-05	0.00243	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	5.77e-05	0.00242	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.61e-05	0.00235	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.57e-05	0.00233	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	5.52e-05	0.00231	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	5.43e-05	0.00227	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.41e-05	0.00227	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	5.34e-05	0.00224	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.34e-05	0.00223	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—LPL—focal segmental glomerulosclerosis	5.28e-05	0.00221	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—LPL—focal segmental glomerulosclerosis	5.28e-05	0.00221	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.27e-05	0.0022	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.21e-05	0.00218	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AGT—focal segmental glomerulosclerosis	5.17e-05	0.00216	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	5.09e-05	0.00213	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	5.06e-05	0.00212	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.05e-05	0.00212	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.89e-05	0.00205	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.85e-05	0.00203	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.84e-05	0.00203	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.79e-05	0.002	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	4.74e-05	0.00198	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	4.71e-05	0.00197	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.69e-05	0.00196	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.66e-05	0.00195	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	4.64e-05	0.00194	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AGT—focal segmental glomerulosclerosis	4.52e-05	0.00189	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AGT—focal segmental glomerulosclerosis	4.52e-05	0.00189	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	4.51e-05	0.00189	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.48e-05	0.00188	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	4.45e-05	0.00186	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.44e-05	0.00186	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.32e-05	0.00181	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.3e-05	0.0018	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.29e-05	0.00179	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.28e-05	0.00179	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.26e-05	0.00178	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.14e-05	0.00173	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.09e-05	0.00171	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.09e-05	0.00171	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	4.08e-05	0.00171	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	4.06e-05	0.0017	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.99e-05	0.00167	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ALB—focal segmental glomerulosclerosis	3.97e-05	0.00166	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	3.96e-05	0.00166	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	3.94e-05	0.00165	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.89e-05	0.00163	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.79e-05	0.00159	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.76e-05	0.00158	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.76e-05	0.00157	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.63e-05	0.00152	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.62e-05	0.00152	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.6e-05	0.00151	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.47e-05	0.00145	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ALB—focal segmental glomerulosclerosis	3.47e-05	0.00145	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ALB—focal segmental glomerulosclerosis	3.47e-05	0.00145	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.46e-05	0.00145	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.44e-05	0.00144	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.43e-05	0.00144	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.41e-05	0.00143	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.33e-05	0.0014	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.32e-05	0.00139	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.3e-05	0.00138	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.29e-05	0.00138	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.2e-05	0.00134	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.2e-05	0.00134	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.12e-05	0.00131	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.07e-05	0.00129	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.04e-05	0.00127	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.02e-05	0.00126	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.01e-05	0.00126	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.99e-05	0.00125	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.87e-05	0.0012	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	2.83e-05	0.00118	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.82e-05	0.00118	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	2.79e-05	0.00117	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.74e-05	0.00115	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.62e-05	0.0011	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.6e-05	0.00109	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.55e-05	0.00107	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.55e-05	0.00107	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.54e-05	0.00106	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.53e-05	0.00106	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.51e-05	0.00105	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	2.42e-05	0.00101	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	2.41e-05	0.00101	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.31e-05	0.000969	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.31e-05	0.000967	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.3e-05	0.000962	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.22e-05	0.000931	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.16e-05	0.000903	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.12e-05	0.000889	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.1e-05	0.000878	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	2.06e-05	0.000861	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.04e-05	0.000855	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2e-05	0.000838	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.98e-05	0.000828	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.95e-05	0.000818	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.95e-05	0.000816	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.94e-05	0.000813	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.89e-05	0.000792	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	1.86e-05	0.000777	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.85e-05	0.000772	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.79e-05	0.00075	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.7e-05	0.000714	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.69e-05	0.000706	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.67e-05	0.0007	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.65e-05	0.00069	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.62e-05	0.000677	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.6e-05	0.000669	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	1.58e-05	0.000661	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.52e-05	0.000635	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.51e-05	0.000634	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.49e-05	0.000626	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.48e-05	0.000622	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.47e-05	0.000615	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.42e-05	0.000594	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.38e-05	0.00058	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.37e-05	0.000573	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.37e-05	0.000572	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.29e-05	0.000542	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.28e-05	0.000537	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.26e-05	0.000529	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.26e-05	0.000526	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.24e-05	0.000521	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.22e-05	0.00051	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.19e-05	0.000499	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.12e-05	0.00047	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.09e-05	0.000455	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.05e-05	0.00044	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.03e-05	0.000431	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.53e-06	0.000399	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	9.05e-06	0.000379	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	8.97e-06	0.000375	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.96e-06	0.000375	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	8.81e-06	0.000369	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	8.45e-06	0.000354	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.05e-06	0.000337	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	7.97e-06	0.000334	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.85e-06	0.000329	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	7.67e-06	0.000321	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.34e-06	0.000307	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	7.23e-06	0.000303	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	6.76e-06	0.000283	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.64e-06	0.000278	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	5.89e-06	0.000246	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	5.55e-06	0.000232	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	5.52e-06	0.000231	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.73e-06	0.000198	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.63e-06	0.000152	CbGpPWpGaD
